Smart Start: Final Results Of Rituximab, Lenalidomide, And Ibrutinib Lead In Prior To Combination With Chemotherapy For Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 24|浏览50
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要